ARQT
Arcutis Biotherapeutics, Inc. · Healthcare
Insider Todd Watanabe sold $1.5M of Arcutis Biotherapeutics, Inc.
Sold$1,517,405
$30.35Price
50,000Shares
−5%Stake
What ARQT did after the filing
- The stock from Tue, Nov 25 open, $30.75
- −8.2%
- S&P 500, same days
- +4.7%
Measured over 30 trading days, to the Jan 9 close.
Traded Fri, Nov 21. Filed Mon, Nov 24, 6:45 PM ET, after the close. Returns use the Nov 25 open and the Jan 9 close. Not investment advice.